But they are a big deal when you start to think who they are selling to -- biotech companies.

The markets will be relieved once we know the winner. It's more important that there's a clear winner than who wins.

The second piece is the volume, (which tells you) how many shares were actually part of this trade. The third part is the price at which the trade was transacted.

I think the market ought to be satisfied with the idea that at least there's not going to be anymore tightening. You know, it's only a couple months ago that people were saying the Fed was going to tighten all through the fall. So now that it looks like they're not, people are saying, wow, maybe they'll ease now. But I think that is quite a way off, probably some time next year.

I think by the time we get to the fourth quarter and next year, things are going to get a lot better.

I think there's a little bit of negative sentiment in the market. Back-to-school sales at retailers were not especially great, and that put a little damper on things. People start focusing on valuations, which is an old story. But valuations are still, you know, pretty high.

Whatever volatility we've seen today can be attributed to oil.

It`s a great story, turning profitable now, ... Their pricing is improving. We look for next year (for the company to post) about $1.80 (a share) in earnings -- about $3 in the following year. So it`s a very timely item here.

Analog Devices makes digital chips that go into cell phones, and there's nothing more hot than that at the moment - you've got cellular phones, which, obviously the world wants to own, plus you've got the chips that go into these phones. These are really the places to be right now.